Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ENVB Enveric Biosciences Inc

3,98

-0,32 (-7,44%)

31 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Article too big to display. Click here to view on the SEC website

Enveric Biosciences (NASDAQ:ENVB)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Enveric Biosciences Charts.

Enveric Biosciences (NASDAQ:ENVB)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Enveric Biosciences Charts.

News Enveric Biosciences Inc

Enveric Biosciences Announces Pricing of $5 Million Public Offering
Freitag 31 Januar 2025 (4 Stunden vor) • Business Wire

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Donnerstag 30 Januar 2025 (7 Stunden vor) • Edgar (US Regulatory)

Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office
Donnerstag 30 Januar 2025 (8 Stunden vor) • Business Wire

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Donnerstag 30 Januar 2025 (16 Stunden vor) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Montag 27 Januar 2025 (4 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 21 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dienstag 14 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Montag 6 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025”
Montag 6 Januar 2025 (4 Wochen vor) • Business Wire

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025”
Montag 6 Januar 2025 (4 Wochen vor) • Business Wire

Form DEF 14A - Other definitive proxy statements
Mittwoch 18 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form PRER14A - Preliminary Proxy Soliciting materials
Donnerstag 12 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Enveric Biosciences Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen